Randomized, Placebo-controlled, Double-blind, Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163 in Healthy Young Male and Elderly Male and Female Chinese Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2012
At a glance
- Drugs Avagacestat (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 19 Jul 2012 Results presented at the 2012 International Conference on Alzheimer's Disease.
- 04 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2011 Planned end date changed from Jan 2011 to Dec 2010 as reported by ClinicalTrials.gov.